Lobe Sciences Ltd.
LOBEF
$0.04
$0.004.65%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.41M | -700.10K | -491.30K | -582.00K | -2.07M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 303.30K | -30.30K | 117.80K | 223.60K | 1.85M |
| Change in Net Operating Assets | 820.20K | 440.10K | 116.80K | 181.70K | 201.50K |
| Cash from Operations | -290.60K | -290.30K | -256.60K | -176.70K | -10.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.23M | -- | -- | -- | -- |
| Cash from Investing | -1.23M | -- | -- | -- | -- |
| Total Debt Issued | -8.34M | 8.33M | 180.20K | -- | 225.70K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.90K | 248.70K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.25M | -248.70K | 248.70K | -- | -- |
| Cash from Financing | 4.10K | 5.92M | 299.70K | -- | 164.80K |
| Foreign Exchange rate Adjustments | -25.10K | 19.30K | -44.00K | 22.40K | -2.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | 5.65M | -900.00 | -154.30K | 152.10K |